+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carac"

U.S. Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical/Drugs, Surgery, Photodynamic Therapy), By Drug Class, By Product, By End-use, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

U.S. Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical/Drugs, Surgery, Photodynamic Therapy), By Drug Class, By Product, By End-use, And Segment Forecasts, 2023 - 2030

  • Report
  • January 2023
  • 150 Pages
  • United States
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Carac market is a segment of the skin cancer drug industry that focuses on the treatment of actinic keratosis (AK). AK is a pre-cancerous skin condition that is caused by long-term exposure to ultraviolet (UV) radiation from the sun. Carac is a topical cream that is used to treat AK and is the only FDA-approved treatment for this condition. The Carac market is a growing segment of the skin cancer drug industry, as the prevalence of AK is increasing due to increased UV exposure. The Carac market is highly competitive, with several major pharmaceutical companies offering their own versions of the drug. These companies include Galderma, Valeant Pharmaceuticals, and LEO Pharma. Additionally, there are several generic versions of Carac available, which are often less expensive than the branded versions. Show Less Read more